| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | levonorgestrel/ethinylestradiol (Rigevidon®) |
| Formulation | 150 micrograms/30 micrograms tablet |
| Reference number | 1026 |
| Indication | Oral contraception |
| Company | Consilient Health UK Ltd |
| BNF chapter | Obstetrics, gynaecology & urinary tract disorders |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 13/04/2011 |